相关实验视频
Updated: Feb 4, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
翻译抑制剂4E-BP1的丧失促进了皮肤致癌的发生
Yibin Zhou1, Hanyu Dou2, Yifeng Liu1
1Department of Pharmacy, Eye and ENT Hospital, Fudan University, Shanghai, China.
细胞转化启动因子4E结合蛋白1 (4E-BP1) 作为皮肤癌中的瘤抑制剂. 4E-BP1的损失促进了角质细胞的增殖和瘤血管生成,突出了翻译.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤状细胞癌 (SCC) 涉及无控制的角质细胞生长和异常的血管形成.
- 细胞转化启动因子4E结合蛋白1 (4E-BP1) 调节蛋白质合成,但其在SCC中的作用尚不清楚.
研究的目的:
- 为了研究4E-BP1在皮肤致癌的功能.
- 为了确定4E-BP1是否在SCC发育中起瘤抑制作用.
主要方法:
- 在4E-BP1缺乏的小鼠中使用了两阶段化学致癌模型.
- 分析小鼠瘤和人类SCC标本的增殖,血管新生和信号通路.
主要成果:
- 缺乏4E-BP1的小鼠显示瘤发育,角质细胞增殖和血管化增加.
- 人类SCC样本显示4E-BP1酸化,增殖,血管生成和mTOR通路激活的增加.
结论:
- 4E-BP1在皮肤癌中起到瘤抑制作用,抑制其增殖和血管生成.
- 失调的翻译有助于SCC的发病,其中4E-BP1发挥着关键作用.
更多相关视频
08:38Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
相关概念视频
Co-activators and Co-repressors
Co-activators and Co-repressors
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...